TARPERPRUMIG
UNII 799C2S3RNC

Substance Identification & Data

This profile provides standardized clinical and technical data for Tarperprumig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 799C2S3RNC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2630946-41-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

799C2S3RNC

CAS Registry Number

2630946-41-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TARPERPRUMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C207000

National Cancer Institute reference terminology for clinical and research data.

INN ID

12204

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-06

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tarperprumig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TARPERPRUMIG

Common Names & Synonyms

IMMUNOGLOBULIN G, BISPECIFIC, ANTI-(HUMAN SERUM ALBUMIN) (HUMAN-LAMA GLAMA MONOCLONAL ALXN1820 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (SYNTHETIC 15 AMINO-ACID) FUSION PROTEIN WITH ANTI-(HUMAN PROPERDIN) (HUMAN-LAMA GLAMA MONOCLONAL ALXN1820 SINGLE-DOMAIN VHH FRAGMENT)

IMMUNOGLOBULIN SINGLE CHAIN VH-VH', AND ANTI-(HOMO SAPIENS ALB (ALBUMIN, HUMAN SERUM ALBUMIN, HSA)), AND ANTI-(HOMO SAPIENS CFP (COMPLEMENT FACTOR PROPERDIN, PROPERDIN)), HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC; SINGLE CHAIN (SC) VH-VH' (1-256) (HUMANIZED VH ANTI-ALB (VICUGNA PACOS IGHV3-3*01 (81.6%) -(IGHD) -IGHJ3*01(92.3%)/HOMO SAPIENS IGHV3-11*05 (80.4%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT (8.7.17) (26-33.51-57.96-112) (1-123)) -14-MER BIS (TETRAGLYCYL-GLUTAMYL) TETRAGLYCYL LINKER (124-137) -HUMANIZED VH ANTI-CFP (VICUGNA PACOS IGHV3S53*01 (81.4%) -(IGHD) -IGHJ4*01, Q123>L (251) (92.3%)/HOMO SAPIENS IGHV3-23*01 (80.2%) -(IGHD) - IGHJ4*01 (100%), CDR-IMGT (8.7.13) (163-170.188-194.233-245) (138-256))), PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1SV, NON-GLYCOSYLATED

IMMUNOGLOBULIN SINGLE CHAIN VH-VH', ANTI-(HOMO SAPIENS ALB (ALBUMIN, HUMAN SERUM ALBUMIN, HSA)) AND ANTI-(HOMO SAPIENS CFP (COMPLEMENT FACTOR PROPERDIN, PROPERDIN)), HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT (SINGLE CHAIN (SC) VH-VH' (1-256) (HUMANIZED VH ANTI-ALB (VICUGNA PACOS IGHV3-3*01 (81.6%) -(IGHD)-IGHJ3*01 (92.3%)/HOMO SAPIENS IGHV3-11*05(80.4%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT (8.7.17) (26-33.51-57.96-112) (1-123)) -14-MER BIS(TETRAGLYCYL-GLUTAMYL) TETRAGLYCYL LINKER (124-137)-HUMANIZED VH ANTI-CFP (VICUGNA PACOSIGHV3S53*01 (81.4%) -(IGHD) -IGHJ4*01, Q123>L (251) (92.3%)/HOMO SAPIENS IGHV3-23*01 (80.2%)-(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.7.13) (163-170.188-194.233-245) (138-256))), PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHOK1SV, NON-GLYCOSYLATED)

TARPERPRUMIG [USAN]